WHO Emergency Committee calls upon member nations for expanding genomic sequencing capacities
GENEVA, July 15 (The CONNECT) – Stating that the pandemic is nowhere near finished, the WHO Emergency Committee on Corona virus has cautioned the world against “the strong likelihood for the emergence and global spread of new and possibly more dangerous variants of concern that may be even more challenging to control.”
The Committee, convened by the WHO Director-General under the International Health Regulations, held its eighth meeting virtually yesterday and noted that, despite national, regional, and global efforts, the pandemic is nowhere near finished. The pandemic continues to evolve with four variants of concern dominating global epidemiology.
The Committee’s Chair, Professor Didier Houssin. Professor Houssin also expressed concern over the current trends with the COVID-19 pandemic and reviewed the objectives and agenda of the meeting.
The Committee unanimously agreed that the COVID-19 pandemic still constitutes an extraordinary event that continues to adversely affect the health of populations around the world, poses a risk of international spread and interference with international traffic, and requires a coordinated international response. As such, the Committee concurred that the COVID-19 pandemic remains a public health emergency of international concern (PHEIC) and offered the following advice to the Director-General.
WHO Director-General Dr Tedros Adhanom Ghebreyesus welcomed the Committee and reiterated his global call for action to scale up vaccination and implement rationale use of public health and social measures (PHSM). He thanked the Committee for their continued support in identifying key challenges and solutions that countries can use to overcome the issues posed by the pandemic.
The Director-General determined that the COVID-19 pandemic continues to constitute a PHEIC. He accepted the advice of the Committee to WHO and issued the Committee’s advice to States Parties as Temporary Recommendations under the IHR.
The Committee expressed appreciation for States Parties engaging in research to increase understanding of COVID-19 vaccines and requested that clinical trial volunteers not be disadvantaged in travel arrangements due to their participation in research studies. At the same time, the risk of emergence of new zoonotic diseases while still responding to the current pandemic has been emphasised by the Committee. The Committee noted the importance of States Parties’ continued vigilance for detection and mitigation of new zoonotic diseases.
The committee stressed the need to continue to strengthen the global monitoring and assessment framework for SARS CoV-2 variants and provide updated guidance to support States Parties in establishing, leveraging, and expanding genomic sequencing capacities as well as timely sharing of information, data, and samples.
The Secretariat also highlighted factors driving the current situation including the variants of concern, inconsistent application of public health and social measures, increased social mobility, and highly susceptible populations due to lack of equitable vaccine distribution.
The Committee discussed key themes including global inequitable access to COVID-19 vaccines which is compounded by use of the available vaccines beyond SAGE recommended priority populations and the administration of booster doses while many countries do not have sufficient access to initial doses; the need for technology transfer to enhance global vaccination production capacity; the importance of adapting PHSM to epidemiological and socio-economic contexts and to diverse types of gatherings; challenges posed by the lack of harmonization in documentation requirements for vaccination and recovery status for international travel; threats posed by current and future SARS CoV-2 variants of concern, and efforts made by some States Parties to apply a risk-management approach to religious or sports-based mass gathering events.
The pandemic remains a challenge globally with countries navigating different health, economic and social demands. The Committee noted that regional and economic differences are affecting access to vaccines, therapeutics, and diagnostics. Countries with advanced access to vaccines and well-resourced health systems are under pressure to fully reopen their societies and relax the PHSM. Countries with limited access to vaccines are experiencing new waves of infections, seeing erosion of public trust and growing resistance to PHSM, growing economic hardship, and, in some instances, increasing social unrest.
As a result, governments are making increasingly divergent policy decisions that address narrow national needs which inhibit a harmonized approach to the global response. In this regard, the Committee was highly concerned about the inadequate funding of WHO’s Strategic Preparedness and Response Plan and called for more flexible and predictable funding to support WHO’s leadership role in the global pandemic response.